mRNA |
ATRA |
CTRPv2 |
pan-cancer |
AAC |
0.32 |
3e-21 |
mRNA |
VNLG/124 |
GDSC1000 |
pan-cancer |
AAC |
0.31 |
3e-21 |
mRNA |
linifanib |
GDSC1000 |
pan-cancer |
AAC |
0.31 |
4e-18 |
mRNA |
AC220 |
GDSC1000 |
pan-cancer |
AAC |
0.29 |
2e-16 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.28 |
3e-16 |
mRNA |
(5Z)-7-Oxozeaenol |
GDSC1000 |
pan-cancer |
AAC |
0.23 |
1e-13 |
mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
5e-12 |
mRNA |
Sorafenib |
CCLE |
pan-cancer |
AAC |
0.31 |
1e-11 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
2e-11 |
mRNA |
Sunitinib |
GDSC1000 |
pan-cancer |
AAC |
0.35 |
2e-11 |